Skip to content

GeneLit

Taming the Medical Literature ~ For Genetic Conditions ~ Hand-Curated • Direct to You

  • Home
  • Subscribe to GeneLit
  • Conditions & Syndromes
    • Genetics of Breast & Ovarian Cancer
  • Topics
  • Contact GeneLit
  • Get LitAlerts
  • Terms and Conditions

Home

    • Efficacy of PARP inhibition combined with EZH2 inhibition depends on BRCA mutation status and microenvironment in breast cancer.
    • Chen MK.
    • FEBS J. 2021 Feb 11. doi: 10.1111/febs.15730. Epub ahead of print.
    • PMID: 33570247
    • PubMed abstract
    • Source abstract
    • Commentary
  • Posted on February 11, 2021February 11, 2021Author Steve KopczakCategories Misc

    Post navigation

    Previous Previous post: Previous Post
    Next Next post: Next Post
    Proudly powered by WordPress